We are handling gastroparesis cases involving Ozempic, Rybelsus, Wegovy, and Trulicity as drug injury lawsuits filed against the responsible pharmaceutical companies.
In this piece, we point out two medical journal articles that present a few gastroparesis cases involving the use of semaglutide (Ozempic, Rybelsus, Wegovy) or dulaglutide (Trulicity):
- Tendency of Semaglutide to Induce Gastroparesis: A Case Report
- Medication-Induced Gastroparesis: A Case Report
Significantly, these medical journal articles provide some helpful information about symptoms and diagnosis of gastroparesis cases that have been associated with Ozempic, Rybelsus, Wegovy, and Trulicity.
In the past six months on our Drug Injury Watch blog, we have written several times about gastroparesis cases involving Ozempic, Rybelsus, and Wegovy.
Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening — Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages (9/1/23)
Severe Stomach Conditions in Patients Using Semaglutide Weight Loss Drugs From Novo Nordisk — Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis (9/13/23)
Ozempic, Wegovy, Other GLP-1 Semaglutide Weight-Loss Drugs Linked to Gastroparesis in Recent Medical Study — Researchers Compared Semaglutide Drugs, Such as Ozempic and Wegovy, to Contrave, a Non-GLP-1 Drug, in Weight-Loss Patients (10/24/23)
As stated above, we are handling drug injury lawsuits for people with gastroparesis cases involving Ozempic, Rybelsus, Wegovy, or Trulicity. If we can assist as regards a possible case, you can contact me by email (TJL@LambLawOffice.com) or phone (800-426-9535).
[View article at original source]Ozempic / Rybelsus / Wegovy/ Trulicity
Free Case Evaluation
Strictly Confidential, No Obligation